Piper Jaffray

VF Corp (NYSE: VFC) shares have already gained more than 60 percent over the past year, but the macro backdrop gives the stock another leg of growth ahead, according to Piper Jaffray. The Analyst Piper Jaffray's Erinn Murphy upgraded VF's stock rating from Neutral to Overweight with a...

PiperJaffray analyst Mike Olson offered a bullish analysis of four major tech stocks on Friday's PreMarket Prep podcast.  Apple Apple Inc (NASDAQ: AAPL)’s first-quarter 2018 earnings report detailed weaker-than-expected iPhone sales, alarming some investors and sending the...

Fiber optic company Applied Optoelectronics Inc (NASDAQ: AAOI) is in for a "brutal" year of competition as well as China's decision to source optical components in-house, according to Piper Jaffray.  The Analyst Piper Jaffray analyst Troy Jensen downgraded shares of Applied...

Finisar Corporation (NASDAQ: FNSR), a manufacturer of optical communication components and subsytems, has historically performed poorly during periods of margin compression, a Piper Jaffray analyst said in a Monday downgrade note.  In reaction to the downgrade — and a Nikkei Asian...

Pre-open movers U.S. stock futures traded lower in early pre-market trade, ahead of earnings reports. Data on personal income and consumer spending for December will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average dropped 26 points to 26,578.00, while the Standard &...

What Happened Philip Morris International Inc. (NYSE: PM) plummeted 6 percent intraday Thursday after the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee rejected one of two claims surrounding its modified risk tobacco product. Why It's Important...

The U.S. stock market has been on such a red-hot run in recent months that even market bulls are starting to say a healthy pull-back could be imminent. On Thursday, Piper Jaffray analyst Craig Johnson said key technical indicators suggest the market has become overbought in the short-term. “...

While Imax Corp (USA) (NYSE: IMAX) may have had some differentiating advantages that gave it a competitive edge in a changing movie business, this may no longer be the case, according to Piper Jaffray.  The Analyst Piper Jaffray's Stan Meyers downgraded Imax's stock rating from...

Amazon.com, Inc. (NASDAQ: AMZN) has had an incredible run in the past decade, gaining more than 1,300 percent. However, one Wall Street analyst says Amazon is nowhere close to peaking. The Analyst Piper Jaffray analyst Michael Olson reiterated an Outperform rating for Amazon and has raised his...

The tax bill signed into law by President Donald Trump will benefit some companies more than others, and analysts at Piper Jaffray identified a "sleeper pick" the firm said is flying under the radar: U.S. Bancorp (NYSE: USB) The Analyst Piper Jaffray's Kevin Barker upgraded U.S...

Groupon Inc (NASDAQ: GRPN) came under heavy selling pressure Tuesday morning in reaction to a report the company's November performance was poor. The Analyst Piper Jaffray's Sam Kemp maintains an Overweight rating on Groupon's stock with an unchanged $6.25 price target. The Thesis...

As consumers seek more bite-sized, on-the-go service reviews, they’re losing appetite for Yelp Inc (NYSE: YELP) and convincing one analyst to try elsewhere. The Rating Piper Jaffray’s Sam Kemp downgraded Yelp to an Underweight rating and lowered the price target from $38 to $37. The...

Here we have it: the largest deal of 2017. CVS Health Corp (NYSE: CVS) confirmed Monday its agreement to acquire Aetna Inc (NYSE: AET) as a standalone business unit for about $207 per share. The parties intend to close the deal in the second half of 2018 to yield $750 million in near-term synergies...

Bank of America (NYSE: BAC) recently upgraded shares of Barclays PLC (ADR) (NYSE: BCS) by two notches from Underperform to Buy. BofA Merrill Lynch cited the underperformance of Barclays' shares and depressed earnings expectations as the reason for its improved assessment. Financial firms are...

Pfizer Inc. (NYSE: PFE)'s pipeline consists of multiple growth assets that may be misunderstood by Wall Street analyst and investors. The Analyst Piper Jaffray's Richard Purkiss maintains an Overweight rating on Pfizer's stock with an unchanged $54 price target. The Thesis Pfizer...